66.18MMarket Cap
LossP/E TTM
Key Figures
6.180Open
6.200High
16.17KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.14%Turnover Ratio
6.405Prev. Close
5.520Low
93.61KTurnover
LossP/E Static
1.92P/B
0.00%Div Yield TTM
-932.76%ROA
13.49052wk High
0.07Volume Ratio
-12.66MNet Profit
11.59MShares
-8.6140EPS TTM
3.47Beta
-1187.72%ROE
1.03052wk Low
31.69%Amplitude
5.09%Gross Margin
66.18MMarket Cap
-0.47Reward/Risk
12.82%Risk Rate

More news coming soon, stay tuned...
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
20.000Target Price
+150.00%Upside Space
Axe Compute Ord Shs Latest Earnings Call Transcripts
Axe Compute (AGPU) Q2 2026 Earnings Call: Signed Contracts Top $3.2 Billion
Axe Compute Q2 2026 revenue rose to $3.2 million as signed contract value exceeded $3.2 billion, with management targeting more than $696 million in ARR.
Financial Indicators
Currency: USD

Relevant data have not been disclosed by the company yet.
Currency: USD

Relevant data have not been disclosed by the company yet.
Earnings
Earnings / Forecast
0.54/-0.29
Revenue / Forecast
7.24M/9.30M
Axe Compute Ord Shs Profile
Axe Compute Inc., formerly Predictive Oncology Inc., is engaged in using artificial intelligence (AI) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy when a tumor sample responds to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Through AI, it uses its proprietary biobank of 150,000+ cancer tumor samples, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of drug development. The Company offers a suite of solutions for oncology drug development from early discovery to clinical trials.
SectorBiotechnology & Medical Research
Ticker SymbolAGPU
Number of employees0
Country
Ownership
| Shareholders | Proportion |
|---|
| DNA Holdings Venture Inc | 4.99% |
|---|
| Okalina Ventures LLC | 4.41% |
|---|
| Alpine Global Management, LLC | 1.55% |
|---|
| Nuzum (Charles Lee Sr) | 0.53% |
|---|
| Shareholder Types | Proportion |
|---|
| Corporation | 9.40% |
|---|
| Investment Advisor | 2.25% |
|---|
| Individual Investor | 2.17% |
|---|
| Investment Advisor/Hedge Fund | 0.44% |
|---|
FAQs
What is the current price of Axe Compute Ord Shs (AGPU)?
The current price of Axe Compute Ord Shs (AGPU) is 5.71.
What is the symbol of Axe Compute Ord Shs?
The ticker symbol of Axe Compute Ord Shs is AGPU.
What is the 52-week high of Axe Compute Ord Shs?
The 52-week high of Axe Compute Ord Shs is 13.49.
What is the 52-week low of Axe Compute Ord Shs?
The 52-week low of Axe Compute Ord Shs is 1.03.
What is the market capitalization of Axe Compute Ord Shs?
The market capitalization of Axe Compute Ord Shs is 66.18M.
Is Axe Compute Ord Shs (AGPU) currently rated as Buy, Hold, or Sell?
According to analysts, Axe Compute Ord Shs (AGPU) has an overall rating of Buy, with a price target of 20.00.
What is the Earnings Per Share (EPS TTM) of Axe Compute Ord Shs (AGPU)?
The Earnings Per Share (EPS TTM) of Axe Compute Ord Shs (AGPU) is -8.61.